Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors, Oncogene, vol.19, pp.2548-56, 2000. ,
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation, Mol Cell Biol, vol.21, pp.1621-1653, 2001. ,
Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors, J Biol Chem, vol.269, pp.24391-24396, 1994. ,
Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science, vol.264, pp.95-103, 1994. ,
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French National Survey, Medicine, vol.91, pp.1-19, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00717018
STAT3 signaling in immunity, Cytokine Growth Factor Rev, vol.31, pp.1-15, 2016. ,
The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature, Medicine, vol.62, pp.195-208, 1983. ,
Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome, J Exp Med, vol.206, pp.1291-301, 2009. ,
Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency, Clin Exp Immunol, vol.159, pp.57-64, 2010. ,
Invasive fungal disease in autosomal-dominant hyper-IgE syndrome, J Allergy Clin Immunol, vol.125, pp.1389-90, 2010. ,
Spectrum of pulmonary aspergillosis in Hyper IgE syndrome with autosomal dominant STAT3 deficiency, J Allergy Clin Immunol Pract, vol.7, pp.1986-95, 2019. ,
The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus, Eukaryot Cell, vol.5, pp.207-218, 2006. ,
Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins, J Biol Chem, vol.293, pp.15538-55, 2018. ,
The Aspergillus fumigatus sialidase (Kdnase) contributes to cell wall integrity and virulence in amphotericin B-treated mice. Front Microbiol, vol.8, p.2706, 2017. ,
The composition of the culture medium influences the ?-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of ?-1,3-glucan synthesis, Antimicrob Agents Chemother, vol.56, pp.3428-3459, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01725799
Aspergillus fumigatus cell wall ?-(1,3)-glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells, J Infect Dis, vol.216, pp.1281-94, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455452
Recombinant antigens as diagnostic markers for aspergillosis, Diagn Microbiol Infect Dis, vol.55, pp.279-91, 2006. ,
Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity, Immunology, vol.130, pp.46-54, 2010. ,
Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells, J Infect, vol.74, pp.81-89, 2017. ,
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria, Clin Exp Allergy, vol.43, pp.850-73, 2013. ,
Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome, J Allergy Clin Immunol, vol.104, pp.1265-72, 1999. ,
Aspergillus felis in patient with chronic granulomatous disease, Emerging Infect Dis, vol.25, pp.2319-2340, 2019. ,
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency, JCI Insight, vol.1, p.89890, 2016. ,
STAT3 mutations in the hyper-IgE syndrome, N Engl J Med, vol.357, pp.1608-1627, 2007. ,
Dominantnegative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome, Nature, vol.448, pp.1058-62, 2007. ,
Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells, J Exp Med, vol.208, pp.235-284, 2011. ,
How neutrophils kill fungi, Immunol Rev, vol.273, pp.299-311, 2016. ,
Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France, Pediatr Infect Dis J, vol.30, pp.57-62, 2011. ,
Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects, J Immunol, vol.196, pp.1272-83, 2016. ,
Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome, Eur J Clin Invest, vol.35, pp.718-739, 2005. ,
Defective in vitro production of gamma-interferon and tumor necrosis factoralpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome, J Clin Invest, vol.84, pp.1830-1835, 1989. ,
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, Lancet Infect Dis, vol.452, pp.393-402, 2008. ,
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies, Blood, vol.100, pp.4521-4529, 2002. ,
Renal allograft recipients fail to increase interferon? during invasive fungal diseases, Am J Transplant, vol.12, pp.3437-3477, 2012. ,
Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis, J Infect Dis, vol.200, pp.1341-51, 2009. ,
Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis, J Infect Dis, vol.172, pp.1554-60, 1995. ,
Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon, Infect Immun, vol.61, pp.1185-93, 1993. ,
Adjunctive interferon-? immunotherapy in a pediatric case of Aspergillus terreus infection, Eur J Clin Microbiol Infect Dis, vol.37, pp.1915-1937, 2018. ,
, A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, N Eng J Med, vol.324, pp.509-525, 1991.
Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients, Am J Transplant, vol.10, pp.1796-803, 2010. ,
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series, BMC Infect Dis, vol.14, p.166, 2014. ,
In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae, J Infect Dis, vol.163, pp.849-52, 1991. ,
Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma, Proc Natl Acad Sci, vol.86, pp.10085-10094, 1989. ,
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells, J Exp Med, vol.205, pp.1543-50, 2008. ,